Literature DB >> 11788066

Characteristics of HIV infection in patients fifty years or older in Michigan.

J N Inungu1, E D Mokotoff, J B Kent.   

Abstract

This study analyzed factors associated with human immunodeficiency virus (HIV) infection among persons ages 50 years or older at HIV diagnosis and examined differences in morbidity and survival between them and those ages 13 to 49 years. HIV-infected persons reported to the Michigan HIV/AIDS registry between January 1990 and October 2000 were analyzed. Of 12,614 HIV-infected persons selected, 938 (7.4%) were ages 50 years or older at HIV diagnosis. Persons ages 50 years or older at HIV diagnosis were twice as likely to be male (odds ratio [OR]: 1.9) than female. They were slightly at higher risk of contracting HIV through blood products (OR: 1.53) or heterosexual contact (OR: 1.24) than through injection drug use, but the difference was not statistically significant. They were twice as likely to report unknown HIV risk (OR: 1.8) than injection drug use and were significantly less likely to be men who have sex with men (OR: 0.64) than injection drug users. The prevalence of selected acquired immune deficiency syndrome (AIDS)-defining conditions was similar between the two age groups. However, HIV dementia was more commonly diagnosed among older persons, whereas disseminated Mycobacterium avium was less commonly diagnosed in this age group. The overall mean survival was significantly shorter among persons ages 50 years or older (73.5 months [standard deviation (SD)]: 2.21 compared with their counterparts [112.3 months (SD: 0.77)], even after adjusting for CD4 count at HIV diagnosis. Older persons appeared to have contracted HIV through heterosexual contact, blood products, or injection drug use and to have a short survival. This age group should no longer be overlooked.

Entities:  

Mesh:

Year:  2001        PMID: 11788066     DOI: 10.1089/108729101753287658

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  7 in total

1.  HIV testing practices among Latina women at risk of getting infected: a five-year follow-up of a community sample in South Florida.

Authors:  Catalina Lopez-Quintero; Patria Rojas; Frank R Dillon; Leah M Varga; Mario De La Rosa
Journal:  AIDS Care       Date:  2015-08-20

2.  Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment.

Authors:  Valerie Wojna; Richard L Skolasky; Rosa Hechavarría; Rául Mayo; Ola Selnes; Justin C McArthur; Loyda M Meléndez; Elizabeth Maldonado; Carmen D Zorrilla; Hermes García; Edmundo Kraiselburd; Avindra Nath
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

3.  A population-based analysis of pneumococcal disease mortality in California, 1989-1998.

Authors:  Matthew D Redelings; Frank Sorvillo; Paul Simon
Journal:  Public Health Rep       Date:  2005 Mar-Apr       Impact factor: 2.792

4.  HIV Dementia.

Authors:  Avindra Nath; Joseph Berger
Journal:  Curr Treat Options Neurol       Date:  2004-03       Impact factor: 3.972

5.  S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS.

Authors:  R Andrew Shippy; Douglas Mendez; Kristina Jones; Irene Cergnul; Stephen E Karpiak
Journal:  BMC Psychiatry       Date:  2004-11-11       Impact factor: 3.630

6.  Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy.

Authors:  Mario Tumbarello; Ricardo Rabagliati; Katleen de Gaetano Donati; Silvia Bertagnolio; Eva Montuori; Enrica Tamburrini; Evelina Tacconelli; Roberto Cauda
Journal:  BMC Infect Dis       Date:  2004-11-06       Impact factor: 3.090

7.  The magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in southern zone Tigray, Ethiopia: a cross-sectional study.

Authors:  Teklay Zeru Weldearegawi; Hadgu Gerensea; Hagos Berihu; Gebreamlak Gidey; Mebrahtom Zeru Welearegay
Journal:  Pan Afr Med J       Date:  2020-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.